A phase 1 study of WT1-expressing artificial adjuvant vector cell (aAVC-WT1) therapy for relapsed and refractory AML

Kawamata, T; Shimizu, K; Yokoyama, K; Nojima, M; Imai, Y; Fujii, S; Tojo, A

CANCER SCIENCE, 2021; 112 (): 405

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索